Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01844206 · ClinicalTrials.gov registry record · Phase 4
Two Dose Epidural Morphine for Post-cesarean Analgesia
A Phase 4 study, sponsored by Columbia University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
NCT01844206 is a Phase 4 study that was terminated before completion, run by Columbia University. The registered enrollment target is 5 participants.
The verdict
NCT01844206, a Phase 4 study, was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
Study Summary
The investigators aim to assess the analgesic effect of a two-dose epidural morphine regimen for 2nd day post-cesarean pain, as part of a multimodal analgesia regimen, which includes scheduled Nonsteroidal anti-inflammatory drugs (NSAIDs). The investigators hypothesize that administration of a second dose of epidural morphine 3 mg, 24 hours after an initial intraoperative dose, will provide superior post-cesarean analgesia during the 2nd 24 hours after surgery, compared to a single epidural morphine dose regimen. The primary outcome will be the amount of intravenous morphine patients self-administer during the 2nd 24 hours post-surgery.
Interventions
- DRUG Epidural Morphine
- DRUG Epidural Saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2013-06 |
| Est. Completion | 2014-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01844206
The ClinicalTrials.gov registry entry for NCT01844206 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Epidural Morphine is the first listed.
NCT01844206 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01844206 about?
NCT01844206 is a clinical study titled "Two Dose Epidural Morphine for Post-cesarean Analgesia". The investigators aim to assess the analgesic effect of a two-dose epidural morphine regimen for 2nd day post-cesarean pain, as part of a multimodal analgesia regimen, which includes scheduled Nonsteroidal anti-inflammatory drugs (NSAIDs). The investigators hypothesize that administration of a secon...
What is the current status of trial NCT01844206?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2013-06. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01844206?
The interventions under investigation include: Epidural Morphine (DRUG), Epidural Saline (DRUG).
Who is sponsoring clinical trial NCT01844206?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.